Editorial Standards

Latest News Today maintains rigorous editorial standards. Our team verifies information from trusted sources and provides context to help readers understand complex stories.

Last Updated: Thursday, October 1, 2026 at 04:54 PM
Category: Id

Editor's Note

Latest News Today provides comprehensive coverage and analysis of breaking news stories. This article is part of our ongoing coverage of wbna7012939, bringing you verified information from trusted sources with added context and expert perspective.

Why This Matters: Understanding the full context of this story helps readers make informed decisions and stay updated on developments that impact our community.

Bipolar disorder more common among poor

Bipolar disorder may often go undiagnosed and untreated in the urban poor, with one in 10 found to have the mental illness in a study of one New York clinic.

Bipolar disorder may often go undiagnosed and untreated in the urban poor, with one in 10 found to have the mental illness in a study of one New York clinic published Tuesday.

The 13-month study at the clinic serving low-income patients found that few reported being diagnosed or treated for the illness.

Bipolar disorder is normally treated with a mood stabilizer such as lithium as well as anti-depressants to counteract the swings from dark moods to mania and associated irritability, racing thoughts, decreased need for sleep, talkativeness, and excessive involvement in risky activities.

Prescribing anti-depressants alone to bipolar patients can trigger manic behavior and rapid “cycling” between mania and depression that could lead to suicidal thoughts, said study author Amar Das of the New York State Psychiatric Institute and Columbia University.

One earlier study estimated bipolar disorder afflicted 5.7 percent of Americans earning less than $20,000 a year, and the illness is more prevalent among the poor than other income groups, the report published in this week’s Journal of the American Medical Association said.

Of the 112 bipolar patients identified in the study, only nine said they had been diagnosed bipolar and only seven said they had taken a mood-stabilizing drug in the past month.

Since the afflicted patients were more likely to seek treatment when they were depressed, not when manic, nearly half had been diagnosed depressive. That diagnosis risked treatment solely with an anti-depressant.

“To improve the recognition and reduce the morbidity of bipolar disorders in primary care, further efforts are needed by primary care physicians to screen selectively for past hypomania or mania among participants with known depression, anxiety, or substance use conditions,” Das wrote.